CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Lilly interested in ibogaine investments, its neuro leader says

ibogainePositive
AI Analysis

Summary

Eli Lilly's neuroscience president Carole Ho said at a psychedelics conference that the company is interested in R&D efforts to improve the profile of ibogaine. Ho joined Lilly last year from Denali Therapeutics.

Importance:4/10
Sentiment:
0.30
psychedelicsibogaineneuroscienceR&Dconference
Related Companies

Read the original article

Published by Endpoints News on October 16, 2026 2:04 PM

Read Original